Skip to main content
CMCAF
OTC Life Sciences

De-SPAC Deal: Piermont Valley to Combine with Tigerless Health, Up to $100M Earnout Planned

Tom Rudovsky · Reported by Wiseek News
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.4
Mkt Cap
$76.286M
52W Low
$9.895
52W High
$12
52W Position info
15% above low
Off High info
5.0% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CMCAF sits 15% above its 52-week low of $9.895.

Summary

Piermont Valley Acquisition Corp (CMCAF) has announced a definitive agreement to combine with Tigerless Health in a de-SPAC transaction, forming a new public parent company, Pubco. This merger represents the successful completion of the SPAC's primary objective. The deal includes a significant earnout of up to $100 million in Pubco Class A shares over four years, contingent on performance. The parties also intend to list Pubco Class A shares on Nasdaq, which could enhance liquidity and visibility for the combined entity. Investors will now focus on the closing of the transaction, potential shareholder redemptions, and the successful listing on Nasdaq.

At the time of this announcement, CMCAF was trading at $11.40 on OTC in the Life Sciences sector, with a market capitalization of approximately $76.3M. The 52-week trading range was $9.90 to $12.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CMCAF - Latest Insights

CMCAF
Mar 10, 2026, 9:53 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $11.40
Real-time Price: $11.00 info
Change: Low Volume info
Market Cap: $65.482M info